Arch Point Investors Astria Therapeutics, Inc. Transaction History

Arch Point Investors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.97 - $10.34 $4,205 - $14,641	-1,416 Reduced 5.5%	24,331 $220,000
Q4 2021 Feb 11, 2022	SELL	$5.08 - $8.62 $12,700 - $21,549	-2,500 Reduced 8.85%	25,747 $139,000
Q3 2021 Nov 12, 2021	BUY	$7.32 - $12.9 $206,768 - $364,386	28,247 New	28,247 $250,000

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $150M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.